Literature DB >> 7981956

The mouse as a model for human cardiovascular disease and hyperlipidemia.

B Paigen1, A S Plump, E M Rubin.   

Abstract

The mouse has been used as an experimental model for atherosclerosis research for only a short time; however, the sophisticated genetics of this species has resulted in a number of innovative approaches that are not possible with other models. The availability of inbred, congenic, recombinant inbred, and mutant strains has resulted in the discovery of a number of genes affecting atherosclerosis susceptibility. More importantly, the newer genetic technologies such as quantitative trait-loci mapping, transgenic mice, and gene-targeted mice are producing important insights into atherosclerosis. This review, focusing on murine models of cardiovascular disease and hyperlipidemia, will be divided into two parts: naturally occurring models and genetically engineered models.

Entities:  

Mesh：

Year:  1994        PMID： 7981956     DOI： 10.1097/00041433-199408000-00003

Source DB:  PubMed          Journal:  Curr Opin Lipidol        ISSN： 0957-9672            Impact factor:   4.776


  11 in total

1.  NMR-based metabolomics of urine for the atherosclerotic mouse model using apolipoprotein-E deficient mice.

Authors:  Gregory C Leo; Andrew L Darrow
Journal:  Magn Reson Chem       Date:  2009-12       Impact factor: 2.447

2.  Generation and mapping of Mus spretus strain-specific markers for rapid genomic scanning.

Authors:  R Elango; L Riba; D Housman; K Hunter
Journal:  Mamm Genome       Date:  1996-05       Impact factor: 2.957

3.  Reduced aortic lesions and elevated high density lipoprotein levels in transgenic mice overexpressing mouse apolipoprotein A-IV.

Authors:  R D Cohen; L W Castellani; J H Qiao; B J Van Lenten; A J Lusis; K Reue
Journal:  J Clin Invest       Date:  1997-04-15       Impact factor: 14.808

4.  Aging enhances contraction to thromboxane A2 in aorta from female senescence-accelerated mice.

Authors:  Susana Novella; Ana Paula Dantas; Gloria Segarra; Laura Novensa; Magda Heras; Carlos Hermenegildo; Pascual Medina
Journal:  Age (Dordr)       Date:  2011-11-19

5.  Development and validation of a novel technique for murine first-pass radionuclide angiography with a fast multiwire camera and tantalum 178.

Authors:  J L Lacy; T Nanavaty; D Dai; N Nayak; N Haynes; C Martin
Journal:  J Nucl Cardiol       Date:  2001 Mar-Apr       Impact factor: 5.952

Review 6.  Genetic modifiers of atherosclerosis in mice.

Authors:  J W Knowles; N Maeda
Journal:  Arterioscler Thromb Vasc Biol       Date:  2000-11       Impact factor: 8.311

7.  Maternal resveratrol supplementation ameliorates bisphenol A-induced atherosclerotic lesions formation in adult offspring ApoE-/- mice.

Authors:  Srinivasa Rao Sirasanagandla; Isehaq Al-Huseini; Mohamed Al Mushaiqri; Nadia Al-Abri; Fatma Al-Ghafri
Journal:  3 Biotech       Date:  2022-01-04       Impact factor: 2.406

8.  Antiobesity and vasoprotective effects of resveratrol in apoE-deficient mice.

Authors:  Seon-Min Jeon; Seung-A Lee; Myung-Sook Choi
Journal:  J Med Food       Date:  2014-01-16       Impact factor: 2.786

9.  Strategies and methods to study sex differences in cardiovascular structure and function: a guide for basic scientists.

Authors:  Virginia M Miller; Jay R Kaplan; Nicholas J Schork; Pamela Ouyang; Sarah L Berga; Nanette K Wenger; Leslee J Shaw; R Clinton Webb; Monica Mallampalli; Meir Steiner; Doris A Taylor; C Noel Bairey Merz; Jane F Reckelhoff
Journal:  Biol Sex Differ       Date:  2011-12-12       Impact factor: 5.027

10.  Poloxamer 407-induced atherosclerosis in mice appears to be due to lipid derangements and not due to its direct effects on endothelial cells and macrophages.

Authors:  Thomas P Johnston; Yuai Li; Ahmed S Jamal; Daniel J Stechschulte; Kottarappat N Dileepan
Journal:  Mediators Inflamm       Date:  2003-06       Impact factor: 4.711
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.